Condensed Consolidated Statements of Stockholders’ Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022		81,259,676
Beginning balance at Dec. 31, 2022	$ 672,435	$ 8	$ 714,871	$ (42,444)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		770,693
Issuance of common stock upon exercise of stock options	6,672		6,672
Issuance of common stock upon settlement of restricted stock units (in shares)		1,469,356
Shares withheld related to net share settlement of restricted stock units (in shares)		(375)
Shares withheld related to net share settlement of restricted stock units	(6)		(6)
Stock-based compensation expense	110,735		110,735
Issuance of common stock under employee stock purchase plan (in shares)		312,134
Issuance of common stock under employee stock purchase plan	5,728		5,728
Net loss	(157,419)			(157,419)
Ending balance (in shares) at Jun. 30, 2023		83,811,484
Ending balance at Jun. 30, 2023	638,145	$ 8	838,000	(199,863)
Beginning balance (in shares) at Mar. 31, 2023		82,600,748
Beginning balance at Mar. 31, 2023	627,208	$ 8	798,898	(171,698)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		439,600
Issuance of common stock upon exercise of stock options	5,135		5,135
Issuance of common stock upon settlement of restricted stock units (in shares)		771,183
Shares withheld related to net share settlement of restricted stock units (in shares)		(47)
Shares withheld related to net share settlement of restricted stock units	(1)		(1)
Stock-based compensation expense	33,968		33,968
Net loss	(28,165)			(28,165)
Ending balance (in shares) at Jun. 30, 2023		83,811,484
Ending balance at Jun. 30, 2023	$ 638,145	$ 8	838,000	(199,863)
Beginning balance (in shares) at Dec. 31, 2023	86,330,303	86,330,303
Beginning balance at Dec. 31, 2023	$ 635,305	$ 9	917,872	(282,576)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)	621,102	621,102
Issuance of common stock upon exercise of stock options	$ 2,219		2,219
Issuance of common stock upon settlement of restricted stock units (in shares)		1,934,708
Shares withheld related to net share settlement of restricted stock units (in shares)		(66)
Shares withheld related to net share settlement of restricted stock units	(2)		(2)
Stock-based compensation expense	71,691		71,691
Issuance of common stock under employee stock purchase plan (in shares)		198,133
Issuance of common stock under employee stock purchase plan	4,565		4,565
Net loss	$ (119,068)			(119,068)
Ending balance (in shares) at Jun. 30, 2024	89,084,180	89,084,180
Ending balance at Jun. 30, 2024	$ 594,710	$ 9	996,345	(401,644)
Beginning balance (in shares) at Mar. 31, 2024		87,805,393
Beginning balance at Mar. 31, 2024	612,798	$ 9	959,963	(347,174)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		269,134
Issuance of common stock upon exercise of stock options	1,015		1,015
Issuance of common stock upon settlement of restricted stock units (in shares)		1,009,681
Shares withheld related to net share settlement of restricted stock units (in shares)		(28)
Shares withheld related to net share settlement of restricted stock units	(1)		(1)
Stock-based compensation expense	35,368		35,368
Net loss	$ (54,470)			(54,470)
Ending balance (in shares) at Jun. 30, 2024	89,084,180	89,084,180
Ending balance at Jun. 30, 2024	$ 594,710	$ 9	$ 996,345	$ (401,644)